Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Skin substitutes & wound grafts · Florida | Skin substitutes & wound grafts · Texas | |
|---|---|---|
| Surgeons, 2024 | 307 | 193 |
| Medicare fee-for-service cases | 65,607 | 48,756 |
| Growth since 2019 (Medicare FFS) | +28%/yr | +22%/yr |
| Forecast cases (Medicare FFS) | 135,200 in 2030 | 79,300 in 2030 |
| Forecast growth | +13%/yr to 2030 | +8.4%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 16.8 | 13.2 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 81% (+45 pts since 2019) | 77% (+30 pts since 2019) |
| Cases per surgeon | 214 | 253 |
| Top 10 surgeons' share | 14% | 25% |
| Surgeons growing | 14 | 17 |
| New since the base year | 237 | 137 |
| Likely to stop billing it | 128 by 2026 | 88 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $5,952 | $7,687 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.